Oral nicotine pouch use is rising, especially among young adult males, prompting closer public health scrutiny.

Patients that use noncigarette tobacco products may have elevated subclinical markers related to inflammation, thrombosis, and atherosclerosis.

Investing.com -- S&P Global Ratings has upgraded Altria Group (NYSE: MO) Inc.’s credit rating to ’BBB+’ from ’BBB’ due to the ...

On May 13, in what was meant to be a curtain-raiser for World No Tobacco Day, the World Health Organisation (WHO) hosted a ...

Q1 2025 Earnings Call Transcript May 13, 2025 22nd Century Group, Inc. misses on earnings expectations. Reported EPS is ...

Global Action to End Smoking is proud to announce a new grant to Northwell Health, New York State's largest health care ...

Governments which impose lower taxes on heated tobacco products in the hope of encouraging smokers away from conventional ...

While cigarettes continue their long, slow decline, nicotine pouches are a bright spot for c-stores and heated tobacco is on ...

Imperial Brands reported a decline in headline revenue on Wednesday, but posted improved earnings per share and maintained ...

As the WHO celebrates the 20th anniversary of the FCTC, it is crucial to acknowledge that the global landscape has changed ...

The rise of emerging tobacco products (ETPs) (ie, e-cigarettes, vaping, heated tobacco products) has added a new dimension to ...

Lawrence Firestone; Chairman of the Board, Chief Executive Officer; 22nd Century Group Inc Daniel Otto; Chief Financial Officer; 22nd Century Group Inc It is now my pleasure to turn the floor over to ...